Magda Kondej
4 A Chodźki St
Lublin, LU 20093, Poland
Lublin, LU 20093, Poland
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 8 publications
The Antipsychotic D2AAK1 as a Memory Enhancer for Treatment of Mental and Neurodegenerative Diseases.
Journal: International journal of molecular sciences
Published: October 30, 2020
Multi-targeted drug design strategies for the treatment of schizophrenia.
Journal: Expert opinion on drug discovery
Published: September 11, 2020
N-(2-Hydroxyphenyl)-1-[3-(2-oxo-2,3-dihydro-1H- benzimidazol-1-yl)propyl]piperidine-4-Carboxamide (D2AAK4), a Multi-Target Ligand of Aminergic GPCRs, as a Potential Antipsychotic.
Journal: Biomolecules
Published: December 15, 2019
Synthesis, pharmacological and structural studies of 5-substituted-3-(1-arylmethyl-1,2,3,6-tetrahydropyridin-4-yl)-1H-indoles as multi-target ligands of aminergic GPCRs.
Journal: European journal of medicinal chemistry
Published: May 31, 2019
Multi-Target Approach for Drug Discovery against Schizophrenia.
Journal: International journal of molecular sciences
Published: September 03, 2018
Synthesis, Structural and Thermal Studies of 3-(1-Benzyl-1,2,3,6-tetrahydropyridin-4-yl)-5-ethoxy-1H-indole (D2AAK1_3) as Dopamine D₂ Receptor Ligand.
Journal: Molecules (Basel, Switzerland)
Published: July 26, 2018
Current Concepts and Treatments of Schizophrenia.
Journal: Molecules (Basel, Switzerland)
Published: July 26, 2018
Showing 1-8 of 8
Last Updated: 09/26/2026